WOMEN'S INTERAGENCY HIV STUDY GYNECOLOGICAL EXAM FORM 8

Similar documents
LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

CLINICAL MANAGEMENT OF STDS

LTASEX.INFO STI SUMMARY SHEETS FOR EDUCATIONAL USE ONLY. COMMERCIAL USE RIGHTS RESERVED. COPYRIGHT 2013, JEROME STUART NICHOLS

Sexually Transmitted Infections in the Adolescent Population. Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System

Sexually Transmitted Infections. Kim Dawson October 2010

Sexual Abuse. Dr Burke Baird

Sexually Transmissible Infections (STI) and Blood-borne Viruses (BBV) A guide for health promotion workers

Female Reproduction. Ova- Female reproduction cells stored in the ovaries

Timby/Smith: Introductory Medical-Surgical Nursing, 9/e

MEMORIAL HOSPITAL SEXUAL ASSAULT MEDICAL/FORENSIC RECORD

Uterine prolapse & Fistulas. Raja Nursing Instructor RN, DCHN, Post RN. BSc.N

SEXUALLY TRANSMITTED INFECTIONS IN ST LOUIS

What's the problem? - click where appropriate.

Case Study 1. Cervical Cancer Screening and Sexually Transmitted Infections Case Studies

Sexually Transmitted Disease Treatment Tables

IN CASE OF AN EMERGENCY NOT LIVING WITH YOU

The Case of Mrs. Virginia Jones* Asst. Professor Division of Gyne-Oncology University of British Columbia, Department of Gynecology Vancouver, Canada

Chapter 11. Sexually Transmitted Diseases

CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION VI. Friday, MARCH 20, 2015 STUDENT COPY

INFORMATION GUIDE FOR GYNAECOLOGICAL CANCER

Sexually Transmitted Diseases: Overview

Level I - Lesson 8: Know Your Body

GUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS

CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6. Friday, MARCH 18, 2016 STUDENT COPY

Curricular Components for Child Sexual Abuse EPA

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR

Sexually Transmitted Diseases: Overview

1. What is your date of birth? Month Day Year

Answers to those burning questions -

The V The word the you cannot say on TV

STI s. (Sexually Transmitted Infections)

STIs: Practical Aspects of Management

MYTHS OF STIs True or False

2/28/2018. This presentation contains images of a graphic nature and are presented for medical education only. New Terminology Old Problem!

Human Papillomavirus (HPV)

Staging and Treatment Update for Gynecologic Malignancies

Rejuvenating the Vagina A GUIDE TO LABIAPLASTY. Your guide to the female form and treatments for vaginal ageing & rejuvenation

Updated Guidelines for Post-Assault Testing and Treatment

Reproductive System. Points to ponder 4/28/2017. Chapter 17 Lecture Outline

Chapter 17 Lecture Outline

The Truth About STDs/STIs. Presented by Denise Piper LPN School Based Health Ed.

Address: 1. What is your vulvar diagnosis (if known)? 2. What is the main symptom for which you are coming to the Vulvar Mucosal Specialty Clinic?

Preventing Sexual Transmitted Diseases

Chlamydia, Gardenerella, and Ureaplasma

Investigation and Management of Vaginal Discharge in Adult Women

How is it transferred?

University Health Services at CMU STI Awareness Month specials for students:

Love Bugs and Drugs Managing Sexually Transmitted Infections in Teens. Renée R. Jenkins, M.D., F.A.A.P. Howard University College of Medicine

Sexually Transmitted Diseases. Ch 24

Chapter 2. Reproductive system matures and becomes capable of reproduction

Section 8. Clinical Considerations

STI Review. CALM: STI/HIV - Lesson One (Handout 3) Bacteria/ Transmission. Symptoms. Disease. Virus

4/3/2017 DIAGNOSIS AND THERAPY OF RECURRENT VULVOVAGINAL SYMPTOMS BACTERIAL VAGINOSIS EPIDEMIOLOGY OBJECTIVES

Grade 9 Science - Human Reproduction

4.05 Remember the structures of the reproductive system

Inner Balance Acupuncture

How to Prevent Sexually Transmitted Diseases

Sexual consequencies of STIs:Chicken or egg. Dr Philip Kell Sexual Medicine Consultant UK

Stephanie. STD Diagnosis and Treatment. STD Screening for Women. Physical Exam. Cervix with discharge from os

Kelly H. Tyler, MD, FACOG, FAAD S052 Gender Dermatology: Diagnosis and Treatment of Genital Skin Disorders Vulvar Dermatitis

Atrophic Vaginitis. Mimi Clarke Secor CHAPTER 23

Vaginitis. Antibiotics Changes in hormone levels due to pregnancy, breastfeeding, or menopause Douching Spermicides Sexual intercourse Infection

Human Papillomavirus (HPV) in Patients with HIV.

Remind me, what s an STI? And why are they relevant to me?

LABORATORY DIAGNOSIS SEXUALLY TRANSMITTED DISEASES

Reproductive System: Male

Sexually Transmitted Infections

Sexual health screening

STI Feud Instructions

Sexually Transmitted Infections (STI) Fact Sheet comprises public domain material from the Office on Women s Health, U.S. Department of Health and

Vulvar cancer: Know what to expect

2/17/2017. Sexually Transmitted Diseases in Children: Is it Abuse? General Considerations. Judy Guinn, MD WI CAN Educational Series February 17, 2017

Sexually Transmitted Diseases. Tr ichomonas. infection. Questions & Answers

New Terminology Old Problem!

Sexual Health Data Standards Phase 2

Women s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins

The Impact of Sexually Transmitted Diseases(STD) on Women

LEARNER OUTCOME 2 W-5.3:

** IMPORTANT!! PLEASE READ THIS BEFORE YOU FILL OUT YOUR QUESTIONNAIRE! **

Chapter 22 Reproductive Systems. Male Reproductive Organs. Male Reproductive Organs. Specialized to produce, maintain the male sex cells (sperm)

Thick white discharge after metronidazole

3/25/2019. J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse

STDs. Sexually Transmitted Diseases. Questions: (Ask Yourself)

Overview of Wet Preps and Gram stains. Lorna Rabe Central Lab Magee-Womens Research Institute Pittsburgh, Pa

CLINICAL PRACTICE RESOURCE FOR HOSPITALS AND EMERGENCY DEPARTMENTS: Evaluation and Management of Suspected Child Abuse or Neglect

Aim #58 STD's. What is the main difference between bacterial STD's and viral STD's? Why is Chlamydia nicknamed the "silent disease?

An All Too Familiar Story

LOUISIANA MEDICAID PROGRAM ISSUED: 11/25/14 REPLACED: 10/16/14 CHAPTER 48: FAMILY PLANNING TAKE CHARGE PLUS APPENDIX A: DIAGNOSIS CODES PAGE(S) 9

The V The word the you cannot say on TV SHELAGH LARSON, WHNP, NCMP UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER

What you need to know to: Keep Yourself SAFE!

Management of Syphilis in Patients with HIV

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16

Sexually Transmi/ed Diseases

THE FEMALE REPRODUCTIVE SYSTEM

MTN-026 Clinical Management Overview

Outline. Male Reproductive System Testes and Sperm Hormonal Regulation

Transcription:

WOMEN'S INTERAGENCY HIV STUDY GYNECOLOGICAL EXAM FORM 8 AFFIX ID LABEL HERE ---> PARTICIPANT ID: (Enter number here only if ID label is not available) - - - WIHS STUDY VISIT #: FORM VERSION: 04/01/99 EXAMINER'S INITIALS: DATE OF GYN EXAM: / / M D Y PARTICIPANT'S DATE OF BIRTH: VERIFY WITH PARTICIPANT / / M D Y TIME MODULE BEGAN: : AM... 1 PM... 2 TIME MODULE ENDED: : AM... 1 PM... 2 SECTION A: GYNECOLOGICAL EXAM A1. EXTERNAL GENITALIA Normal Abnormal Not Done a. Thighs 1 2 (PROMPT) 3 b. Pubis 1 2 (PROMPT) 3 c. Vulva 1 2 (PROMPT) 3 d. Perineum 1 2 (PROMPT) 3 e. Perianal 1 2 (PROMPT) 3 PROMPT: COMPLETE LESION CHART (LOCATED AT A19, PAGE 3) AFTER COMPLETING THE EXAM A2. VAGINA Present Absent a. Erythema 1 2 b. Atrophy 1 2 A3. VAGINAL ph. A4. VAGINAL DISCHARGE VOLUME NORMAL... 1 INCREASED... 2 A5. VAGINAL DISCHARGE COLOR WHITE/CLEAR... 1 YELLOW/GREEN... 2 BROWN/BLOOD... 3 A6. VAGINAL DISCHARGE CHARACTER (CIRCLE ALL APPROPRIATE) NORMAL (MUCOID/FLOCCULAR)... 1 PURULENT... 2 CURDY... 3 MILKY/CREAMY (NON-FLOCCULAR)... 4 FROTHY... 5 BLOODY... 6 CERVICAL EXAMINATION A7. CERVIX PRESENT ABSENT... 2 (A14) A8. CERVICAL EXAMINATION A9. DONE... 1 NOT DONE... 2 REASON: (A12) Present Absent Page 1 of 8

a. Lesions 1 (PROMPT) 2 b. Visible ectopy 1 2 c. Friability 1 2 PROMPT: COMPLETE LESION CHART (LOCATED AT A19, PAGE 3) AFTER COMPLETING THE EXAM A10. EXUDATE ABSENT... 2 (A12) A11. CERVICAL DISCHARGE COLOR WHITE/CLEAR... 1 YELLOW/GREEN... 2 BROWN/BLOOD... 3 A12. CERVICAL MOTION TENDERNESS ABSENT... 2 UTERINE EXAMINATION A13. UTERUS PRESENT ABSENT... 2 (A14) a. UTERINE TENDERNESS PRESENT... 1 b. UTERINE ENLARGEMENT PRESENT... 1 ADNEXAL EXAMINATION A14. ADNEXAE PRESENT ABSENT... 2 (A15) a. RIGHT ADNEXAL TENDERNESS PRESENT... 1 b. LEFT ADNEXAL TENDERNESS PRESENT... 1 c. RIGHT ADNEXAL MASS PRESENT... 1 d. LEFT ADNEXAL MASS PRESENT... 1 A15. CUL-DE-SAC MASS ABSENT... 2 A16. ANUS Done Present Absent Not a. External hemorrhoid 1 2 3 b. Discharge 1 2 3 c. Anal tenderness 1 2 3 A17. RECTAL EXAM DONE YES... 1 NO... 2 DECLINED... <-7> A18. ANAL FISSURE PRESENT YES... 1 NO... 2 Page 2 of 8

GYNECOLOGICAL EXAM ABNORMALITY/LESION CHART A19. WERE ANY ABNORMALITIES/LESIONS PRESENT ON THE GYN EXAM? PLEASE INCLUDE THOSE ABNORMALITIES NOTED AT QUESTIONS A1 AND A9. YES... 1 NO... 2 (A44, PAGE 6) A. TOTAL NUMBER OF LOCATIONS WITH LESIONS: LOCATIONS: 01 - Labia Majora (left) 16 - Vagina (right internal) 02 - Labia Majora (right) 17 - Vagina (left internal) 03 - Labia Minora (left) 18 - Cervical Os 04 - Labia Minora (right) 19 - Inner upper left quad 05 - Introitus (left) 20 - Inner lower left quad 06 - Introitus (right) 21 - Inner lower right quad 07 - Perineum (left) 22 - Inner upper right quad 08 - Perineum (right) 23 - Outer upper left quad 09 - Inguinal (left) 24 - Outer lower left quad 10 - Inguinal (right) 25 - Outer lower right quad 11 - Thigh (left) 26 - Outer upper right quad 12 - Thigh (right) 27 - Anus upper left 13 - Clitoris 28 - Anus lower left 14 - Urethra 29 - Anus lower right 15 - Pubis 30 - Anus upper right 31-3 or more locations Page 3 of 8

START F08S1 A20. LOCATION #1 IF LOCATION CODE=31, SPECIFY LOCATIONS: LOCATION CODE Lesion Type Yes No a. How Many? b. Size (Width by Length in mm's) A21. Wart 1 2(A22) x c. Depth (Ulcer Only) 1 = superficial (1-2 mm) 2 = moderate (3-4 mm) 3 = deep (5mm and over) A22. Ulcer 1 2(A23) x 1 2 3 A23. Rash 1 2(A24) x A24. Mass 1 2(A25) x A25. Other 1 2(A26) x PROMPT: ENTER "99" IN COLUMN a. IF TOO MANY TO COUNT. IF NO OTHER LOCATIONS WITH LESIONS, SKIP TO A44, PAGE 6. A26. LOCATION #2 IF LOCATION CODE=31, SPECIFY LOCATIONS: LOCATION CODE Lesion Type Yes No a. How Many? b. Size (Width by Length in mm's) A27. Wart 1 2(A28) x c. Depth (Ulcer Only) 1 = superficial (1-2 mm) 2 = moderate (3-4 mm) 3 = deep (5mm and over) A28. Ulcer 1 2(A29) x 1 2 3 A29. Rash 1 2(A30) x A30. Mass 1 2(A31) x A31. Other 1 2(A32) x PROMPT: ENTER "99" IN COLUMN a. IF TOO MANY TO COUNT. IF NO OTHER LOCATIONS WITH LESIONS, SKIP TO A44, PAGE 6. A32. LOCATION #3 IF LOCATION CODE=31, SPECIFY Page 4 of 8

LOCATION CODE LOCATIONS: Lesion Type Yes No a. How Many? b. Size (Width by Length in mm's) A33. Wart 1 2(A34) x c. Depth (Ulcer Only) 1 = superficial (1-2 mm) 2 = moderate (3-4 mm) 3 = deep (5mm and over) A34. Ulcer 1 2(A35) x 1 2 3 A35. Rash 1 2(A36) x A36. Mass 1 2(A37) x A37. Other 1 2(A38) x PROMPT: ENTER "99" IN COLUMN a. IF TOO MANY TO COUNT. IF NO OTHER LOCATIONS WITH LESIONS, SKIP TO A44, PAGE 6. A38. LOCATION #4 IF LOCATION CODE=31, SPECIFY LOCATIONS: LOCATION CODE Lesion Type Yes No a. How Many? b. Size (Width by Length in mm's) A39. Wart 1 2(A40) x c. Depth (Ulcer Only) 1 = superficial (1-2 mm) 2 = moderate (3-4 mm) 3 = deep (5mm and over) A40. Ulcer 1 2(A41) x 1 2 3 A41. Rash 1 2(A42) x A42. Mass 1 2(A43) x A43. Other 1 2(A44) x PROMPT: ENTER "99" IN COLUMN a. IF TOO MANY TO COUNT. IF NO OTHER LOCATIONS WITH LESIONS, SKIP TO A44, PAGE 6. END F08S1 Page 5 of 8

A44. EXAM SITE TESTS POSITIVE NEGATIVE UNCLEAR NOT OBTAINED a. WET PREP/SALINE MOUNT i. trichomonas 1 2 3 4 5 ii. clue cells 1 2 3 4 5 iii. increased wbcs (i.e., > 1:1 wbc:epithelial 1 2 3 4 5 cells) b. KOH MOUNT i. yeast 1 2 3 4 5 ii. amine odor 1 2 3 4 5 SECTION B: CLINICAL IMPRESSION YES NO B1. Pregnancy 1 2 B2. Menopause 1 2 B3. Normal overall clinical impression 1 (END) 2 NOT READ YES, CAUSE UNKNOWN B4. Vaginitis 1 2 (B5) 3 (B5) a. candidal 1 2 b. trichomonal 1 2 c. Bacterial Vaginosis 1 2 B5. Cervicitis (gc/non-gc) 1 2 B6. PID 1 2 B7. Proctitis 1 2 (B8) 3 (B8) a. gc/non-gc 1 2 b. herpetic 1 2 B8. Herpes 1 2 (B9) a. primary/first episode 1 2 b. recurrent episode 1 2 c. chronic ulceration 1 2 B9. Molluscum 1 2 B10. Syphilis 1 2 (B11) a. chancre 1 2 b. rash/secondary 1 2 Page 6 of 8

YES NO B11. Wart 1 2 (B12) a. vulvar 1 2 b. vaginal 1 2 c. cervical 1 2 d. anal 1 2 e. other genital 1 2 B12. Other cervical abnormality 1 2 B13. Other vaginal abnormality 1 2 B14. Uterine enlargement 1 2 B15. Other anal abnormality B16. Other vulvar abnormality 1 2 1 2 B17. Adnexal mass (not PID) 1 2 (END) a. Right 1 2 b. Left 1 2 PROMPT: ANY FINDINGS SUGGESTIVE OF SEXUAL OR PHYSICAL ABUSE ARE TO BE FOLLOWED UP BY THE CLINICIAN AND REFERRED TO THE APPROPRIATE REFERRAL SOURCES (i.e., LOCAL SOCIAL SERVICE AND/OR LAW ENFORCEMENT AGENCY). PROMPT: COMPLETE "TIME MODULE ENDED" ON PAGE 1 OF THE FORM. PLEASE NOTE: ANY NECESSARY ADDITIONAL COMMENTS SHOULD BE WRITTEN IN THE SPACE PROVIDED ON THE FOLLOWING PAGE. Page 7 of 8

ADDITIONAL COMMENTS Page 8 of 8